Get the Stockscreener App
3.62
5.97%
-0.23
After Hours:
3.66
0.04
+1.10%
Cardlytics Inc stock is traded at $3.62, with a volume of 76,120.
It is down -5.97% in the last 24 hours and down -32.46% over the past month.
Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.
See More
Previous Close:
$3.85
Open:
$3.86
24h Volume:
76,120
Relative Volume:
0.96
Market Cap:
$21.02M
Revenue:
$205.69M
Net Income/Loss:
$-104.00M
P/E Ratio:
-0.1781
EPS:
-20.3294
Net Cash Flow:
$-3.60M
1W Performance:
-13.40%
1M Performance:
-32.46%
6M Performance:
-70.08%
1Y Performance:
-86.62%
1-Day Range:
$3.62
$3.9499
1-Week Range:
$3.62
$4.2199
52-Week Range:
$3.62
$32.80
Cardlytics Inc Stock (CDLX) Company Profile
Name
Cardlytics Inc
Sector
Industry
Phone
888-798-5802
Address
675 PONCE DE LEON AVENUE, NE, ATLANTA, GA
Compare CDLX vs APP, OMC, WPP, LFTO, MGNI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDLX
Cardlytics Inc
|
3.62 | 22.36M | 205.69M | -104.00M | -3.60M | -20.33 |
APP
Applovin Corp
|
391.98 | 133.99B | 6.16B | 3.91B | 4.40B | 11.34 |
OMC
Omnicom Group Inc
|
79.66 | 22.20B | 19.82B | 159.00M | 2.99B | 0.3998 |
WPP
Wpp Plc Adr
|
18.75 | 3.91B | 17.86B | -233.30M | 720.44M | -1.3469 |
LFTO
Liftoff Mobile Inc
|
22.14 | 3.77B | 0 | 0 | 0 | 0.00 |
MGNI
Magnite Inc
|
18.51 | 2.57B | 722.55M | 158.66M | 32.62M | 1.0355 |
Cardlytics Inc Stock (CDLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-11-24 | Initiated | Evercore ISI | In-line |
| Aug-16-24 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-15-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-08-24 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-08-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-08-24 | Downgrade | Needham | Buy → Hold |
| Jun-20-24 | Resumed | BofA Securities | Neutral |
| Jun-18-24 | Initiated | Northland Capital | Outperform |
| Mar-15-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-29-23 | Initiated | Lake Street | Buy |
| Sep-08-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-14-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-12-22 | Downgrade | Craig Hallum | Buy → Hold |
| Apr-05-22 | Resumed | Wells Fargo | Overweight |
| Jun-18-21 | Initiated | Needham | Buy |
| Apr-15-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-14-21 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-05-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-14-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-28-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-21-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Mar-04-20 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-15-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-02-19 | Initiated | Craig Hallum | Buy |
| Nov-14-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-09-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-24-19 | Reiterated | BofA/Merrill | Buy |
| Jul-01-19 | Initiated | William Blair | Outperform |
| Jan-15-19 | Upgrade | BofA/Merrill | Neutral → Buy |
View All
Cardlytics Inc Stock (CDLX) Latest News
Cardlytics (CDLX) Announces Q2 Earnings Date and Growth Projecti - GuruFocus
Cardlytics stock trades in a narrow range as revenue stabilizes after restructuring - AD HOC NEWS
Cardlytics schedules Aug. 5 webcast after market close for Q2 - Stock Titan
Press Release: Cardlytics to Report Second Quarter 2026 Results on August 5 - Moomoo
Cardlytics to Report Second Quarter 2026 Results on August 5 - Business Wire
Cardlytics (CDLX) Stock Forum and Discussion - Moomoo
CDLX6046219 Bond Risk Profile - TradingView
CDLX6046219 Bond Profile — Key Metrics - TradingView
CDLX6046219 Bond Coupon Profile — Rate & Payments - TradingView
Cardlytics Is Trying To Rebuild Its Bank-Offer Engine - Finimize
CDLX Q1 2026 Earnings: EPS Surprises 49.45% Above Estimates, Stock Gains 3.85%Earnings Analysis - Bölüm Sonu Canavarı
Q1 2025 Cardlytics Inc Earnings Call Transcript - GuruFocus
Price to book forward of Cardlytics, Inc. Common Stock – NASDAQ:CDLX - TradingView
Price to book forward of Cardlytics, Inc. – MUN:CYX0 - TradingView
Cardlytics CEO Amit Gupta sells over $70k in company stock - Investing.com Australia
Cardlytics chief legal & privacy officer sells $9,453 in stock - Investing.com
Cardlytics (CDLX) CEO sells shares following RSU conversions and split - Stock Titan
Form 4 Cardlytics Inc For: 6 July By Investing.com - Investing.com Canada
Cardlytics chief legal & privacy officer sells $9,453 in stock By Investing.com - Investing.com Canada
Amit Gupta (CDLX) proposes sale of 9,640 shares after restricted stock vesting - Stock Titan
CDLX Q1 2026 Earnings: EPS Beat by a Wide Margin Offsets Revenue Reporting GapsEarnings Revision Upgrade - dars.gov.et
Press Release: Cardlytics Announces Timing of Its First Quarter 2026 Earnings Release - Moomoo
Earnings call transcript: Cardlytics beats EPS expectations in Q1 2026 - Investing.com
CDLXCardlytics Inc Latest SEC Filings - Finviz
Enterprise value to EBITDA forward of Cardlytics, Inc. Common Stock – NASDAQ:CDLX - TradingView
Enterprise value to EBITDA forward of Cardlytics, Inc. – LSX:A42D32 - TradingView
Enterprise value to EBIT forward of Cardlytics, Inc. Common Stock – NASDAQ:CDLX - TradingView
Cardlytics (CDLX) Edges Higher as Trading Volume Signals Cautious OptimismMonthly Profile - dars.gov.et
Form 144 Cardlytics For: 2 July By Investing.com - Investing.com India
CDLX (CDLX) Rule 144: 6,498 restricted shares vest; insider transfers reported - Stock Titan
[144] Cardlytics, Inc. SEC Filing - Stock Titan
Price to earnings forward of Cardlytics, Inc. – LSX:A42D32 - TradingView
CARDLYTICS INC Actuals & Estimates (GETTEX:CYX) - TradingView
Price to sales forward of Cardlytics, Inc. Common Stock – NASDAQ:CDLX - TradingView
CDLX Q1 2026 Earnings: EPS Beat Narrows Losses as Cost Discipline Takes Center StageBalance Sheet Strength - dars.gov.et
Cardlytics (CDLX) Faces Continued Pressure, Testing Key Support at $4.47Last Point Resistance - dars.gov.et
Enterprise value to revenue forward of Cardlytics, Inc. Common Stock – NASDAQ:CDLX - TradingView
Price to book forward of Cardlytics, Inc. – FWB:CYX0 - TradingView
Enterprise value to revenue forward of Cardlytics, Inc. – FWB:CYX0 - TradingView
Gross margin % of Cardlytics, Inc. – GETTEX:CYX0 - TradingView
Cardlytics Inc (CDLX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cardlytics (CDLX) Gains 4.2% as Stock Approaches Key Resistance at $5.46Motive Wave - dars.gov.et
CDLX News | CARDLYTICS INC (NASDAQ:CDLX) - ChartMill
Cardlytics Inc (CDLX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cardlytics Inc (CDLX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cardlytics Inc (CDLX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cardlytics Inc (CDLX) Institutional Confidence - TradingKey
Cardlytics Inc (CDLX) Valuation: PE, PB & Fair Value Analysis - TradingKey
CDLX|Cardlytics Inc|Price:5.200|Chg%:0.21 - TradingKey
Cardlytics Inc (CDLX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cardlytics Inc (CDLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cardlytics Inc Stock (CDLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.87%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):